The Scientist

» drug development and evolution

Most Recent

image: Evolution of Fish Bioluminescence

Evolution of Fish Bioluminescence

By | June 9, 2016

Fish evolved to make their own light at least 27 times, according to a study.

1 Comment

The change should allow patients with fatal illnesses easier access to experimental drugs, but gaining permission from drug companies remains the biggest challenge.

0 Comments

A transposon underlies this classic story of evolutionary adaptation.

1 Comment

Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.

1 Comment

image: Start Making Sense

Start Making Sense

By | June 1, 2016

Scientific progress is only achieved when humans' innate sense of understanding is validated by objective reality.

6 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.

2 Comments

Caltech’s Frances Arnold is honored for her work on directed evolution.

1 Comment

image: Pfizer Scoops Anacor for $5.3 Billion

Pfizer Scoops Anacor for $5.3 Billion

By | May 17, 2016

The acquisition-hungry pharmaceutical firm is purchasing the California-based eczema gel maker.

0 Comments

image: Genome Digest

Genome Digest

By | May 17, 2016

What researchers are learning as they sequence, map, and decode species’ genomes  

0 Comments

image: Mysterious Eukaryote Missing Mitochondria

Mysterious Eukaryote Missing Mitochondria

By | May 12, 2016

Researchers uncover the first example of a eukaryotic organism that lacks the organelles.

5 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech